HiTech Health opened a new facility in Galway designed to advance the development, manufacturing and testing of sterile formulations such as cell and gene therapies. 

As a Contract Development and Manufacturing Organisation (CDMO) HiTech Health’s new facility in Galway is certified by the Health Products Regulatory Authority (HPRA) complying with all European standards.  

HiTech Health is the first Irish company to secure a licence to contract manufacture cell and gene therapies on behalf of client biotech and biopharma companies. 

Their team of experts facilitates the transformation of a promising new therapy idea from initial development to the GMP manufacture of a drug to treat patients in clinical environment, helping to accelerate the journey of advanced therapies towards commercialisation.

The newly established manufacturing center is equipped with cutting-edge technology designed to advance the development, production, and testing of sterile formulations.

“I am delighted to announce the opening of this manufacturing centre that offers our clients  capacity for GMP manufacture of these life-changing medicines for treating patients. Partnerships and collaboration are at the core of successful research and innovation and this is a major focus for Hitech Health. Advanced Medicines including cell and gene therapy products is the fastest-growing sector of new product development.  There were 7 new advanced medicines approved by the FDA in 2023.  This number is expected to increase to between 10-20 per year by 2025.  Hitech Health is  a company with the capability to support the development of these new therapies in this fast growing area of medicines which is pivotal for treating patients with rare disease.”

Brian Harrison, Managing Director of Hitech Health